Synteract

Broad Therapeutic Expertise Across Phase I-IV
Clinical Development

As the complexity and rigor of drug development increases, it is important to work with an experienced contract research organization that has a solid understanding of the clinical development process combined with a depth and breadth of therapeutic expertise. SynteractHCR is a full-service CRO with a more than two decade track record of success supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. We have broad experience in a wide range of therapeutic areas handling both drug, diagnostic and device trials, contributing to numerous product approvals since our founding.

Whether your trial is a single-dose, placebo-controlled clinical trial, a rescue study, or even a device or diagnostic trial, SynteractHCR collaborates with every client to tailor an approach to fit your specific project needs. We provide customized Phase I through IV clinical development services internationally, across multiple therapeutic areas including a notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology.

We’ve worked in the following therapeutic areas:

Related Links

Well-rounded experience.

SynteractHCR has conducted
trials across all major
therapeutic areas and
we have contributed 
to more than 200
product approvals
since our
founding.
Learn More




Contact SynteractHCR

  • USA: +1 760 268 8200
  • Europe: +49 89 12 66 80 0
  • Contact Form...

Contact SynteractHCR

Tell us how to stay in touch with you:


Required Fields(*)
Cancel